Use of genetically engineered mice as models for understanding human neurodegenerative disease

Journal of the American Geriatrics Society

Volumn 44, Issue 6, 1996, Pages 717-722

  Andersen, Julie K ^a,b,c   Jurma, Octavian P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC ENGINEERING; HUNTINGTON CHOREA; MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; REVIEW; TISSUE CULTURE; TRANSGENIC MOUSE;

EID: 15844421384     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01839.x     Document Type: Review

References (34)

1. Yuasa S. Developmental mechanisms of neural network in the cerebellar system. Nihon Shinkei Seishin Yakurigaku Zasshi 1995;15:177-183.
2. Copeland NG, Jenkins NA, Gilbert DJ et al. A genetic linkage map of the mouse: Current applications and future prospects. Science 1993;262:57-66.
3. Palmiter RD, Brinster R. Transgenic mice. Cell 1985;41:343-345.
4. Capecchi MR. The new mouse genetics: Altering the genome by gene targeting. Trends Genet 1989;5:70-76.
5. Capecchi MR. Altering the genome by homologous recombination. Science 1989;244:1288-1292.
6. Rosen DR, Siddique T, Patterson P et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
7. Ripps ME, Huntley GW, Hof PR et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci 1995;92:689-693.
8. Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-1775.
9. Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-1116.
10. Figlewicz D, Krizus A, Martinoli MG et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994;3:1757-1761.
11. Collard JF, Cote F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995;375:61-64.
12. Vickers JC, Morrison JH, Friedrich VL Jr et al. Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit. J Neurosci 1994;14:5603-5612.
13. Gusella JF, MacDonald ME, Ambrose CM et al. Molecular genetics of Huntington's disease. Arch Neurol 1993;50:1157-1163.
14. Duyao M. P., Auerbach AB, Ryan A et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995;269:407-410.
15. Fry M, Loeb LA. The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc Natl Acad Sci 1994;91:4950-4954.
16. Burright EN, Brent Clark KH, Servadio A et al. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995;82:937-948.
17. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
18. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
19. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
20. Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778.
21. Quon D, Wang Y, Catalano R et al. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 1991;352:239-241.
22. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993;90:1977-1981.
23. Games D, Adams D, Alessandrini R et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995;373:523-527.
24. Cohen G. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv Neurol 1986;45:119-125.
25. Graham DG. Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 1984;5:83-95.
26. Hirsch EC. Why are catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol 1992;32(suppl):S88-93.
27. Beal F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992;31:119-130.
28. Sofic E, Paulus W, Jellinger K et al. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991;56:978-982.
29. Ben-Shacher D, Eschel G, Riederer P et al. Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease. Ann Neurol 1992;32(suppl):S105-110.
30. Westlund KN, Denney RM, Kochersperger LM et al. Distinct monoamine oxidase A and B populations in primate brain. Science 1985;230:181-183.
31. Andersen JK, Frim DM, Isacson O et al. Catecholaminergic cell atrophy in a transgenic mouse aberrently overexpressing MAO-B in neurons. Neurodegeneration 1994;3:97-109.
32. Cases O, Seif I, Grimsby J. et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995;268:1763-1766.
33. Brunner HG, Nelen M, Breakefield XO et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993;262:578-580.
34. Ozelius LJ, Breakefield XO. Co-factor insufficiency in dystonia-parkinsonian syndrome. Nature Genet 1994;8:207-209.